Journal article

Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia

Abstract:: Not available.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Murphy, T., Zou, J., Arruda, A., Wang, T. T., Zhao, Z., Zheng, Y., Gupta, V., Maze, D., McNamara, C., Minden, M. D., Schimmer, A., Sibai, H., Yee, K., Capo-Chichi, J.-M., Stockley, T., Schuh, A., Bratman, S. V., & Chan, S. M. (2023). Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia. Haematologica, 109(2), 671–675.

MLA Style

Murphy, T, et al. “Exclusion of Persistent Mutations in Splicing Factor Genes and Isocitrate Dehydrogenase 2 Improves the Prognostic Power of Molecular Measurable Residual Disease Assessment in Acute Myeloid Leukemia.” Haematologica, vol. 109, no. 2, 2023, pp. 671–75.

Chicago Style

Murphy, T, J Zou, A Arruda, et al. 2023. “Exclusion of Persistent Mutations in Splicing Factor Genes and Isocitrate Dehydrogenase 2 Improves the Prognostic Power of Molecular Measurable Residual Disease Assessment in Acute Myeloid Leukemia.” Haematologica 109 (2): 671–75.
Print

Access Document

Files:: Murphy_et_al_2023_Exclusion_of_persistent.pdf

(Preview, Version of record, pdf, 2.6MB, Terms of use)

Publisher copy:: 10.3324/haematol.2023.283510

Authors

+ Murphy, T More by this author

Role:: Author
ORCID:: 0000-0001-5198-0406

+ Zou, J More by this author

Role:: Author
ORCID:: 0000-0002-4309-0961

+ Arruda, A More by this author

Role:: Author
ORCID:: 0000-0003-2516-8005

+ Wang, TT More by this author

Role:: Author

+ Zhao, Z More by this author

Role:: Author
ORCID:: 0000-0001-5825-5346

More authors...

Publisher:: Ferrata Storti Foundation
Journal:: Haematologica More from this journal
Volume:: 109
Issue:: 2
Pages:: 671-675
Publication date:: 2023-06-22
DOI:: 10.3324/haematol.2023.283510
EISSN:: 1592-8721
ISSN:: 0390-6078

Language:: English
Keywords:: Minimal residual disease

Medicine

Mutation

Oncology

Cancer research

Biology

Computer science

Residual

Biochemistry

Leukemia

Disease

Enzyme

Myeloid leukemia

IDH1

Internal medicine

Gene

Isocitrate dehydrogenase

Genetics

RNA splicing
Pubs id:: 1718853
Local pid:: pubs:1718853
Source identifiers:: W4381597464
Deposit date:: 2026-06-08
ARK identifier:: ark:/29072/ora_0e2ba6155ea34fdeaca3482fadc54476

Terms of use

Copyright date:: 2023

Licence:: CC Attribution-NonCommercial (CC BY-NC)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP